Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 11, 2016
Preclinical models of muscle spasticity: valuable tools in the development of novel treatment for neurological diseases and conditionsAnton Bespalov, Liudmila Mus, Edwin Zvartau
Current Psychiatry Reports|July 20, 2010
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not availableEvgeny Krupitsky, Edwin Zvartau, George Woody
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 29, 2016
Antagonist Models for Relapse Prevention and Reducing HIV RiskGeorge E Woody, Evgeny Krupitsky, Edwin Zvartau
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2010
Effects of alcohol withdrawal on cardiovascular systemSeppo Kähkönen, Edwin Zvartau, Jari Lipsanen, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|September 1, 2007
Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawalSeppo Kähkönen, Boris Bondarenko, Jari Lipsanen, et al.
European Journal of Pharmacology|February 20, 2003
Effects of morphine on formalin-induced nociception in ratsNatalia Sevostianova, Edwin Zvartau, Anton Bespalov, et al.
Psychopharmacology|March 13, 2017
mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?Olga A Dravolina, Edwin Zvartau, Wojciech Danysz, et al.
Alcoholism, Clinical and Experimental Research|January 26, 2007
Alcohol use in pregnant and nonpregnant Russian womenArlinda F Kristjanson, Sharon C Wilsnack, Edwin Zvartau, et al.
Pageof 4